The $2 Trillion COVID-19 Stimulus Law and Its Impact on the Health Care Industry
Webinar | 04.01.20, 12:00 PM EDT - 1:00 PM EDT
On Friday, Congress passed the COVID-19 Stimulus Law in its most recent installment of critical legislation responding to the COVID-19 pandemic. As expected, the legislation includes a number of health care provisions aimed at addressing emergency drug and device shortages; increasing access to care for patients with COVID-19 while providing additional safeguards for other patients; and offering financial relief in the form of, for example, additional appropriations waiving patient cost-sharing, delaying payment reductions, and additional reimbursement.
For more information, please visit these areas: Government Contracts
Contact
Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 10.08.25
Webinar | 09.29.25
False Claims Act and Customs Enforcement—What You Need to Know
Webinar | 09.25.25
